|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 413/04 | |
| C07D 413/14 | |||
| A61K 31/42 | |||
| A61K 31/4245 | |||
| A61K 31/44 | |||
| A61P 3/00 |
| (11) | Patento numeris | 2205595 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 08804779.0 |
| Europos patento paraiškos padavimo data | 2008-09-26 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-07-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-09-10 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2008/062900 |
| Data | 2008-09-26 |
| (87) | Numeris | WO 2009/040410 |
| Data | 2009-04-02 |
| (30) | Numeris | Data | Šalis |
| 976064 P | 2007-09-28 | US |
| (72) |
KWAK, Young-Shin, US
COPPOLA, Gary Mark, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | OXADIAZOLE- AND OXAZOLE-SUBSTITUTED BENZIMIDAZOLE- AND INDOLE-DERIVATIVES AS DGAT1 INHIBITORS |
| OXADIAZOLE- AND OXAZOLE-SUBSTITUTED BENZIMIDAZOLE- AND INDOLE-DERIVATIVES AS DGAT1 INHIBITORS |